CHIRON CAPITAL MANAGEMENT, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1830922 TALLAHASSEE, FL

Position in BMRN

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$334,737

+$186,381 QoQ

Shares Held

5,850

+200.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#373

of 561 holders

Holding Since

Sep 2020

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $1,195,948 across 5 Biotechnology names. BMRN ranks #1 (28.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc This page	5,850	$334,737
2	DFTX	Definium Therapeutics, Inc.	7,000	$329,280
3	ATAI	AtaiBeckley Inc.	50,126	$264,164
4	TGTX	Tg Therapeutics, Inc.	3,800	$208,772
5	PGEN	Precigen, Inc.	10,350	$58,995

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$334,737	5,850	+200.0%	Shares	Sole	2026-07-21
2020-09-30	$148,356	1,950	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.